5 results match your criteria: "Prof. Dr. Ilhan Varank Education and Training Hospital[Affiliation]"

Article Synopsis
  • This systematic review explores the use of artificial intelligence (AI) in diagnosing and treating urolithiasis (kidney stones), highlighting its potential to improve accuracy and effectiveness in medical practice.
  • The study analyzed 71 original AI research papers, revealing that AI achieved high precision rates in stone composition (88.2%) and detection (96.9%), as well as solid accuracy in predicting stone passage and treatment outcomes (around 82-87%).
  • The findings suggest that AI could significantly enhance management strategies for urolithiasis, but further research is needed to cement its role in routine clinical use.
View Article and Find Full Text PDF

Objectives: To investigate the effects of increasing propolis doses on salivary glands exposed to radiotherapy (RT).

Methods: Thirty-seven rats were divided into 4 groups: The control group (G0, n: 7), G1 group (n: 10), G2 group (n: 10), and G3 group (n: 10). The rats in the G1 group received 15 Gray (Gy) RT only to the head and neck area.

View Article and Find Full Text PDF

Aim: This study aimed to describe the baseline characteristics of coronavirus disease 2019 (COVID-19) patients with pulmonary embolism, and to examine the Geneva score, pulmonary embolism severity index (PESI), radiological and biochemical findings.

Methods: From March 2020 to June 2021, the files of 41 COVID-19 patients with pulmonary embolism were accessed.

Results: Mean D-dimer value was 6.

View Article and Find Full Text PDF

In this study, we aimed to determine the late relapse rate in hepatitis C patients with sustained virological response after interferon-based regimens, and evaluated the predictors of late relapse while comparing the real-life data of our country with that of others. A multicenter retrospective study was performed to investigate the data of patients infected with HCV who obtained sustained virological response after classical or pegylated interferon alpha (PegIFNα) and ribavirin (RBV) for 48 weeks. Sustained virological response was based on negative HCV RNA level by PCR at the end of six months after the therapy.

View Article and Find Full Text PDF